May 27, 2020
Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19
May 20, 2020
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus
Apr 28, 2020
Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus (COVID-19) Infections
Apr 20, 2020
BGI Group helping over 80 countries for timely COVID-19 detection and intervention
Mar 17, 2020
Pneumagen Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
Mar 11, 2020
Airway Therapeutics Announces Filing with NIH to Evaluate AT-100 as a Therapy for Novel Coronavirus
Dec 31, 2019
Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028
Nov 04, 2019
Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028
Oct 09, 2019
New Research Examines Key Players Involved in Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Targeted Therapeutics Markets and Key Projects
Sep 30, 2019
Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology
Sep 27, 2019
Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek(TM) 2019
Sep 27, 2019
Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
Sep 10, 2019
Pneumagen Ltd Demonstrates Preclinical Proof-of-Concept for Neumifil(TM) in Respiratory Syncytial Virus Infections
Sep 08, 2019
Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019
Sep 03, 2019
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults
Jul 30, 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology
Jul 29, 2019
Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting
Jan 24, 2019
Sobi(TM) Completes Acquisition of Synagis® US Rights From AstraZeneca and Exercises Authorisation to Issue Shares